[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Laboratory-developed Testing-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data

December 2021 | 131 pages | ID: L960352E0EFBEN
MIReports Co., Limited

US$ 3,680.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Laboratory-developed Testing-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Laboratory-developed Testing industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Top 20 Countries Market Size of Laboratory-developed Testing 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Laboratory-developed Testing worldwide and market share by regions, with company and product introduction, position in the Laboratory-developed Testing market
Market status and development trend of Laboratory-developed Testing by types and applications
Cost and profit status of Laboratory-developed Testing, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Laboratory-developed Testing market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Laboratory-developed Testing industry.

The report segments the global Laboratory-developed Testing market as:

Global Laboratory-developed Testing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa

Global Laboratory-developed Testing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Commercial Service
R&D

Global Laboratory-developed Testing Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Genetic Testing
Oncology
Infectious Disease
Others

Global Laboratory-developed Testing Market: Manufacturers Segment Analysis (Company and Product introduction, Laboratory-developed Testing Sales Volume, Revenue, Price and Gross Margin):
Adaptive Biotechnologies Corporation
Quest Diagnostics
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Biotheranostics
Adaptive Biotechnologies
Rosetta Genomics
Biodesix
Helix

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF LABORATORY-DEVELOPED TESTING

1.1 Definition of Laboratory-developed Testing in This Report
1.2 Commercial Types of Laboratory-developed Testing
  1.2.1 Commercial Service
  1.2.2 R&D
1.3 Downstream Application of Laboratory-developed Testing
  1.3.1 Genetic Testing
  1.3.2 Oncology
  1.3.3 Infectious Disease
  1.3.4 Others
1.4 Development History of Laboratory-developed Testing
1.5 Market Status and Trend of Laboratory-developed Testing 2016-2026
  1.5.1 Global Laboratory-developed Testing Market Status and Trend 2016-2026
  1.5.2 Regional Laboratory-developed Testing Market Status and Trend 2016-2026

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Laboratory-developed Testing 2016-2021
2.2 Sales Market of Laboratory-developed Testing by Regions
  2.2.1 Sales Volume of Laboratory-developed Testing by Regions
  2.2.2 Sales Value of Laboratory-developed Testing by Regions
2.3 Production Market of Laboratory-developed Testing by Regions
2.4 Global Market Forecast of Laboratory-developed Testing 2022-2026
  2.4.1 Global Market Forecast of Laboratory-developed Testing 2022-2026
  2.4.2 Market Forecast of Laboratory-developed Testing by Regions 2022-2026

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Sales Volume of Laboratory-developed Testing by Types
3.2 Sales Value of Laboratory-developed Testing by Types
3.3 Market Forecast of Laboratory-developed Testing by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Global Sales Volume of Laboratory-developed Testing by Downstream Industry
4.2 Global Market Forecast of Laboratory-developed Testing by Downstream Industry

CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

5.1 North America Laboratory-developed Testing Market Status by Countries
  5.1.1 North America Laboratory-developed Testing Sales by Countries (2016-2021)
  5.1.2 North America Laboratory-developed Testing Revenue by Countries (2016-2021)
  5.1.3 United States Laboratory-developed Testing Market Status (2016-2021)
  5.1.4 Canada Laboratory-developed Testing Market Status (2016-2021)
  5.1.5 Mexico Laboratory-developed Testing Market Status (2016-2021)
5.2 North America Laboratory-developed Testing Market Status by Manufacturers
5.3 North America Laboratory-developed Testing Market Status by Type (2016-2021)
  5.3.1 North America Laboratory-developed Testing Sales by Type (2016-2021)
  5.3.2 North America Laboratory-developed Testing Revenue by Type (2016-2021)
5.4 North America Laboratory-developed Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

6.1 Europe Laboratory-developed Testing Market Status by Countries
  6.1.1 Europe Laboratory-developed Testing Sales by Countries (2016-2021)
  6.1.2 Europe Laboratory-developed Testing Revenue by Countries (2016-2021)
  6.1.3 Germany Laboratory-developed Testing Market Status (2016-2021)
  6.1.4 UK Laboratory-developed Testing Market Status (2016-2021)
  6.1.5 France Laboratory-developed Testing Market Status (2016-2021)
  6.1.6 Italy Laboratory-developed Testing Market Status (2016-2021)
  6.1.7 Russia Laboratory-developed Testing Market Status (2016-2021)
  6.1.8 Spain Laboratory-developed Testing Market Status (2016-2021)
  6.1.9 Benelux Laboratory-developed Testing Market Status (2016-2021)
6.2 Europe Laboratory-developed Testing Market Status by Manufacturers
6.3 Europe Laboratory-developed Testing Market Status by Type (2016-2021)
  6.3.1 Europe Laboratory-developed Testing Sales by Type (2016-2021)
  6.3.2 Europe Laboratory-developed Testing Revenue by Type (2016-2021)
6.4 Europe Laboratory-developed Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

7.1 Asia Pacific Laboratory-developed Testing Market Status by Countries
  7.1.1 Asia Pacific Laboratory-developed Testing Sales by Countries (2016-2021)
  7.1.2 Asia Pacific Laboratory-developed Testing Revenue by Countries (2016-2021)
  7.1.3 China Laboratory-developed Testing Market Status (2016-2021)
  7.1.4 Japan Laboratory-developed Testing Market Status (2016-2021)
  7.1.5 India Laboratory-developed Testing Market Status (2016-2021)
  7.1.6 Southeast Asia Laboratory-developed Testing Market Status (2016-2021)
  7.1.7 Australia Laboratory-developed Testing Market Status (2016-2021)
7.2 Asia Pacific Laboratory-developed Testing Market Status by Manufacturers
7.3 Asia Pacific Laboratory-developed Testing Market Status by Type (2016-2021)
  7.3.1 Asia Pacific Laboratory-developed Testing Sales by Type (2016-2021)
  7.3.2 Asia Pacific Laboratory-developed Testing Revenue by Type (2016-2021)
7.4 Asia Pacific Laboratory-developed Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

8.1 Latin America Laboratory-developed Testing Market Status by Countries
  8.1.1 Latin America Laboratory-developed Testing Sales by Countries (2016-2021)
  8.1.2 Latin America Laboratory-developed Testing Revenue by Countries (2016-2021)
  8.1.3 Brazil Laboratory-developed Testing Market Status (2016-2021)
  8.1.4 Argentina Laboratory-developed Testing Market Status (2016-2021)
  8.1.5 Colombia Laboratory-developed Testing Market Status (2016-2021)
8.2 Latin America Laboratory-developed Testing Market Status by Manufacturers
8.3 Latin America Laboratory-developed Testing Market Status by Type (2016-2021)
  8.3.1 Latin America Laboratory-developed Testing Sales by Type (2016-2021)
  8.3.2 Latin America Laboratory-developed Testing Revenue by Type (2016-2021)
8.4 Latin America Laboratory-developed Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

9.1 Middle East and Africa Laboratory-developed Testing Market Status by Countries
  9.1.1 Middle East and Africa Laboratory-developed Testing Sales by Countries (2016-2021)
  9.1.2 Middle East and Africa Laboratory-developed Testing Revenue by Countries (2016-2021)
  9.1.3 Middle East Laboratory-developed Testing Market Status (2016-2021)
  9.1.4 Africa Laboratory-developed Testing Market Status (2016-2021)
9.2 Middle East and Africa Laboratory-developed Testing Market Status by Manufacturers
9.3 Middle East and Africa Laboratory-developed Testing Market Status by Type (2016-2021)
  9.3.1 Middle East and Africa Laboratory-developed Testing Sales by Type (2016-2021)
  9.3.2 Middle East and Africa Laboratory-developed Testing Revenue by Type (2016-2021)
9.4 Middle East and Africa Laboratory-developed Testing Market Status by Downstream Industry (2016-2021)

CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF LABORATORY-DEVELOPED TESTING

10.1 Global Economy Situation and Trend Overview
10.2 Laboratory-developed Testing Downstream Industry Situation and Trend Overview

CHAPTER 11 LABORATORY-DEVELOPED TESTING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

11.1 Production Volume of Laboratory-developed Testing by Major Manufacturers
11.2 Production Value of Laboratory-developed Testing by Major Manufacturers
11.3 Basic Information of Laboratory-developed Testing by Major Manufacturers
  11.3.1 Headquarters Location and Established Time of Laboratory-developed Testing Major Manufacturer
  11.3.2 Employees and Revenue Level of Laboratory-developed Testing Major Manufacturer
11.4 Market Competition News and Trend
  11.4.1 Merger, Consolidation or Acquisition News
  11.4.2 Investment or Disinvestment News
  11.4.3 New Product Development and Launch

CHAPTER 12 LABORATORY-DEVELOPED TESTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

12.1 Adaptive Biotechnologies Corporation
  12.1.1 Company profile
  12.1.2 Representative Laboratory-developed Testing Product
  12.1.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Adaptive Biotechnologies Corporation
12.2 Quest Diagnostics
  12.2.1 Company profile
  12.2.2 Representative Laboratory-developed Testing Product
  12.2.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Quest Diagnostics
12.3 Roche
  12.3.1 Company profile
  12.3.2 Representative Laboratory-developed Testing Product
  12.3.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Roche
12.4 Illumina
  12.4.1 Company profile
  12.4.2 Representative Laboratory-developed Testing Product
  12.4.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Illumina
12.5 Qiagen
  12.5.1 Company profile
  12.5.2 Representative Laboratory-developed Testing Product
  12.5.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Qiagen
12.6 Eurofins
  12.6.1 Company profile
  12.6.2 Representative Laboratory-developed Testing Product
  12.6.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Eurofins
12.7 Guardant Health
  12.7.1 Company profile
  12.7.2 Representative Laboratory-developed Testing Product
  12.7.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Guardant Health
12.8 Biotheranostics
  12.8.1 Company profile
  12.8.2 Representative Laboratory-developed Testing Product
  12.8.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Biotheranostics
12.9 Adaptive Biotechnologies
  12.9.1 Company profile
  12.9.2 Representative Laboratory-developed Testing Product
  12.9.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Adaptive Biotechnologies
12.10 Rosetta Genomics
  12.10.1 Company profile
  12.10.2 Representative Laboratory-developed Testing Product
  12.10.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Rosetta Genomics
12.11 Biodesix
  12.11.1 Company profile
  12.11.2 Representative Laboratory-developed Testing Product
  12.11.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Biodesix
12.12 Helix
  12.12.1 Company profile
  12.12.2 Representative Laboratory-developed Testing Product
  12.12.3 Laboratory-developed Testing Sales, Revenue, Price and Gross Margin of Helix

CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF LABORATORY-DEVELOPED TESTING

13.1 Industry Chain of Laboratory-developed Testing
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF LABORATORY-DEVELOPED TESTING

14.1 Cost Structure Analysis of Laboratory-developed Testing
14.2 Raw Materials Cost Analysis of Laboratory-developed Testing
14.3 Labor Cost Analysis of Laboratory-developed Testing
14.4 Manufacturing Expenses Analysis of Laboratory-developed Testing

CHAPTER 15 REPORT CONCLUSION

CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Reference


More Publications